Poly(methyl methacrylate)-block-polysulfide-block-poly(methyl methacrylate) copolymers obtained by free-radical polymerization combined with oxidative coupling

Summary Poly(methyl methacrylate)-block-polysulfide-block-poly(methyl methacrylate) copolymers were synthesized for the first time through a new method involving the free radical polymerization of MMA in the presence of a thiocol oligomer as a chain transfer agent, followed by chemical oxidation of the remaining SH end-groups. The chain transfer constant of the SH end-groups of the thiocol was estimated from the rate of consumption of the thiol groups versus the rate of consumption of the monomer (C_T=0.67). The triblock copolymers synthesized were characterized by SEC and ¹H NMR measurements.     

Reliability of degrading dynamic systems

Methods are developed for finding the reliability of Daniels systems and plates with cracks that are subjected to dynamic random load processes. Reliability of these systems is defined, respectively, as the probability that there is at least an unfailed fiber and crack length does not exceed a critical value during a reference period. Properties of conditional mean crossing rates and diffusion models are used in analysis.     

Monitoring TRPC7 Conformational Changes by BRET Following GPCR Activation

Transient receptor potential canonical (TRPC) channels are membrane proteins involved in regulating Ca²⁺ homeostasis, and whose functions are modulated by G protein-coupled receptors (GPCR). In this study, we developed bioluminescent resonance energy transfer (BRET) biosensors to better study channel conformational changes following receptor activation. For this study, two intramolecular biosensors, GFP10-TRPC7-RLucII and RLucII-TRPC7-GFP10, were constructed and were assessed following the activation of various GPCRs. We first transiently expressed receptors and the biosensors in HEK293 cells, and BRET levels were measured following agonist stimulation of GPCRs. The activation of GPCRs that engage Gα_q led to a Gα_q-dependent BRET response of the functional TRPC7 biosensor. Focusing on the Angiotensin II type-1 receptor (AT₁R), GFP10-TRPC7-RLucII was tested in rat neonatal cardiac fibroblasts, expressing endogenous AT₁R and TRPC7. We detected similar BRET responses in these cells, thus validating the use of the biosensor in physiological conditions. Taken together, our results suggest that activation of Gα_q-coupled receptors induce conformational changes in a novel and functional TRPC7 BRET biosensor.     

Phthalonitrile‐containing poly(amide imide)s with nanoactuation properties

A series of aromatic poly(amide imide)s containing pendant phthalonitrile groups was prepared by solution polycondensation reaction of 4,4′‐diamino‐4″‐(3,4‐dicyanophenoxy)triphenylmethane, 1, or of different amounts of 1 and 1,3‐bis(4‐aminophenoxy)benzene, with a fluorinated imide diacid chloride, 2,2‐bis[N‐(4‐chloroformylphenyl)phthalimidyl]hexafluoroisopropane. The polymers were easily soluble in polar organic solvents, such as N‐methyl‐2‐pyrrolidone, N,N‐dimethylacetamide, N,N‐dimethylformamide, and dimethylsulfoxide. They can be cast from solutions into thin flexible films showing nanoactuation properties in the range of 120–450 nm, depending on the nitrile group content, when an electric voltage is applied on their surface. Electrical insulating properties of the polymer films were evaluated on the basis of dielectric permittivity and dielectric loss and their variation with the frequency and temperature. The values of the dielectric permittivity at 10 kHz and 20°C were in the range of 3.01–3.43. All polymers exhibited high thermal stability, decomposition temperature being above 420°C. POLYM. ENG. SCI., 2013. © 2012 Society of Plastics Engineers     

Electrochemical behavior of a new <Emphasis Type="Italic">s</Emphasis>-triazine-based dendrimer

The electrochemical behavior of a new G-2-s-triazine-based dendrimer, 2,4,6-tris-{4-{4,6-bis-{4-{4,6-bis-[(1S,2S)-1,3-dihydroxy-1-(4-nitrophenyl)-prop-2-ylamino]-s-triazin-2-yl}-piperazin-1-yl}-s-triazin-2-yl}-piperazin-1-yl}-s-triazine, (I), was studied in dimethylsulfoxide solution by cyclic voltammetry, on platinum and graphite electrodes. The electrochemical properties of I were compared with that of one of its precursor, N-{4,6-bis{4-{4,6-bis[(1S,2S)-1,3-dihydroxy-1-(4-nitrophenyl)-prop-2-ylamino]-s-triazin-2-yl}-piperazin-1-yl}-triazin-2-yl}-piperazine), (II), together with that of the starting material, (1S,2S)-2-amino-1-(4-nitrophenyl)-propane-1,3-diol (“p-nitrophenylserinol”), (III).     

THE ENERGETIC STABILITY OF TORI AND SINGLE-WALL TUBES

Tessellated tori, generated here from square-like tiled lattices, are closely related to cylinders and capped tubes. This way of building them enables the orientation of their bonds, and so the geometric proportions of the torus, to be specified for molecular mechanics calculations and, along with their transformation into capped tubes this is illustrated and discussed in the light of their energetic stability.     

Promising Therapies for Atrial Fibrillation and Ventricular Tachycardia

Sudden cardiac death due to arrhythmias, such as atrial fibrillation or ventricular tachycardia, account for 15–20% of all deaths. Myocardial infarction increases the burden of atrial fibrillation and ventricular tachycardia by structural and electrical remodeling of the heart. The current management of new-onset atrial fibrillation includes electric cardioversion with very high conversion rates and pharmacologic cardioversion, with less a than 50% conversion rate. If atrial fibrillation cannot be converted, the focus becomes the control of the symptoms ensuring a constant rhythm and rate control, without considering other contributory factors such as autonomic imbalance. Recently, a huge success was obtained by developing ablation techniques or addressing the vagal nerve stimulation. On the other hand, ventricular tachycardia is more sensitive to drug therapies. However, in cases of non-responsiveness to drugs, the usual therapeutic choice is represented by stereotactic ablative therapy or catheter ablation. This review focuses on these newly developed strategies for treatment of arrhythmias in clinical practice, specifically on vernakalant and low-level tragus stimulation for atrial fibrillation and stereotactic ablative therapy for drug-refractory ventricular tachycardia. These therapies are important for the significant improvement of the management of atrial fibrillation and ventricular tachycardia, providing: (1) a safer profile than current therapies, (2) higher success rate than current solutions, (3) low cost of delivery.